Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery

Figure 1

Experimental workflow for magnetic hyperthermia in vivo. After tumor implantation, magnetic nanoparticles (MNP) were applied intratumorally 24 h prior to the first magnetic hyperthermia treatment (60 minutes, alternating magnetic field (AMF) H = 15.5 kA m−1, f = 435 kHz). Seven days later a second hyperthermia treatment was performed. Tumor volume, blood count and MNP distribution were monitored by micro computed tomography (μCT) on the indicated days. After the experimental period of 28 days the animals were sacrificied and the tumors dissected.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us